An observational study in Stroke, sponsored by Seyoung Shin. Recruiting at 1 site in South Korea. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2026-03-25.
Sponsored by Seyoung Shin · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 279 studies in Stroke with a site in Korea, Republic of — 41 open to participants now, 49 under way, 2 of them phase 3. Stroke · Korea, Republic of.
Among the 279 studies in Stroke with a site in Korea, Republic of, this one is the 50th largest by planned enrollment of the 61 observational ones that give a count, is one of 14 that started in 2025, is one of 62 observational ones, reaches primary completion later than 27 of the 48 other live ones, and was the 269th registered.
8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.
Browse Stroke studies →41 of the 279 studies in Stroke with a site in Korea, Republic of are open now. Recruiting first, the newest first:
Seyoung Shin · Sites in Korea, Republic of
Ages 19+ · Healthy volunteers
Yonsei University · Sites in Korea, Republic of
Ages 19+
Yonsei University · Sites in Korea, Republic of
Ages 19–80
S&Ebio Co. Ltd. · Sites in Korea, Republic of
Ages 19+
Yonsei University · Sites in Korea, Republic of
Ages 19+
A study can be open while its sites in Korea, Republic of have not opened yet or have stopped. Only those recruiting at a site in Korea, Republic of →
Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.
This study: 20 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
279 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 12 · Phase 2 13 · Phase 3 38 · Phase 4 21
First in 2003; this study’s year is marked. 14 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 70 is below the median of 150 across 1,971 observational studies indexed under Stroke.
Median enrollment 50 across the 215 interventional studies, 150 across the 61 observational. Of the 177 that completed or were terminated, 28 (16%) have results posted.
This tab as a report to print or save as PDF → With an account.
60 of 279 have an industry lead sponsor. The 10 most frequent:
Seyoung Shin is the lead sponsor of 3 studies on the registry; 2 are open to participants now.
Seyoung Shin has 3 studies filed under Stroke — fewer than ten, so there is no comparison to draw.
8 of the studies in Stroke with a site in Korea, Republic of that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07558876Jisu KimTask-Oriented Upper Limb Training With Focal Vibration in Stroke | 2026-12 |
| NCT06752096Navigantis Inc.Robot-Assisted Neurovascular Intervention | 2026-12-01 |
| NCT07570264Nunaps IncLEXURE for Post-Stroke Aphasia | 2026-12-30 |
| NCT07322107Pusan National University Yangsan HospitalPrefrontal Brain Activity and ECG Patterns in Stroke and Healthy Adults | 2026-12-31 |
| NCT07482579Seyoung ShinDevelopment of Stroke Prognosis Predictive Precision Medicine Based on a Digital Twin | 2026-12-31 |
Add all 8 to your calendar (.ics) → With an account.
Among the 279 studies in Stroke with a site in Korea, Republic of, from their registry updates:
This tab as a report to print or save as PDF → With an account.
To collect large-scale, high-quality clinical data, daily activity and movement patterns, and genomic information from stroke patients spanning the subacute to chronic stages.
This study aims to establish the foundation for personalized precision medicine in stroke care and to develop a visual and digital transformation of patient medical information in the era of digital healthcare.
This study aims to establish a comprehensive, high-quality dataset that captures the longitudinal characteristics of stroke recovery from the subacute to chronic stages. By integrating clinical data, daily activity and movement patterns, and genomic information, the study reflects the multidimensional nature of stroke in a real-world setting.
The collected data will support data-driven approaches in stroke care by enabling a better understanding of individual variability in recovery trajectories and facilitating the development of predictive models for functional outcomes.
In addition, this study seeks to contribute to personalized precision medicine by enabling individualized interpretation of patient data. It also supports the digital transformation of healthcare by facilitating structured, visual, and data-driven representations of patient medical information for improved clinical and research applications.
Stroke patients receiving treatment at two hospitals in Korea
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients diagnosed with stroke at two hospitals in Korea
Other: Stroke
No intervention
Modified Barthel Index (MBI)
A scale to measure disability or dependence in activities of daily living (ADL) of stroke survivors (range 0-100)
Time frame: minimum <1 months to maximum 6 months
Mini Mental Status Examination (MMSE)
Mini-Mental State Examination (MMSE) is a 30-question assessment of cognitive function that evaluates attention and orientation, memory, registration, recall, calculation, language and ability to draw a complex polygon (range 0-30)
Time frame: minimum <1 months to maximum 6 months
Functional Ambulatory Category (FAC)
The Functional Ambulation Categories (FAC) is a 6-point functional walking test that evaluates ambulation ability, determining how much human support the patient requires when walking, regardless of whether or not they use a personal assistive device. (range 0-5)
Time frame: minimum <1 months to maximum 6 months
Fugl-Meyer Assessment (FMA)
The Fugl-Meyer Assessment (FMA) is a performance-based scale used to evaluate motor functioning, balance, sensation, and joint functioning in patients who have experienced a stroke. The motor domain (score range 0-100) assesses movement, coordination, and reflexes of the upper and lower extremities, with higher scores indicating better motor recovery.
Time frame: minimum <1 months to maximum 6 months
Started Nov 2025 (actual). Primary completion is estimated for Dec 2026, 13 months after the start.
Of 838 non-industry observational studies under Stroke, half reached primary completion within 41 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 92. This study's planned 13 months is below that.
Counting every sponsor, half of 900 studies reached it within 40 months; a quarter within 18 and three quarters within 85.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.